Clinical trial
Radiofrequency Ablation Under Ideal Conditions in Hepatocellular Carcinoma
NCT01669668 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiofrequency Ablation Under Ideal Conditions in Hepatocellular Carcinoma
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- December 31, 2014
- Completion date
- December 31, 2018
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.